<DOC>
	<DOCNO>NCT01180530</DOCNO>
	<brief_summary>This study conduct Asia , Europe North America . The aim observational study evaluate safety NovoPen Echo速 collect safety information ( incidence technical complaint related adverse reaction ) . Study duration : 12-18 week .</brief_summary>
	<brief_title>Observational Study NovoPen Echo速 Safety Treatment Satisfaction Children Adolescents With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Children/adolescents type 1 diabetes mellitus After participate physician 's decision make initiate treatment NovoPen Echo速 , patient meet inclusion criterion meet exclusion criterion , eligible participate Use insulin pen syrinx least 12 month Insulin pump Insuflon速 users Any disease condition children/adolescents might interfere study individual physician 's discretion</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>